Effect of Liraglutide, Metformin, and Gliclazide on Body Composition in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease-A Randomised Trial

被引：0
|
作者：
Feng, Wenhuan
Bi, Yan
Li, Ping
Yin, Tingting
Gao, Caixia
Shen, Shanmei
Gao, Lijun
Jiang, Can
Zhu, Dalong
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1344-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients
    Department of Digestive Medicine
    Hepatobiliary&PancreaticDiseasesInternational, 2005, (03) : 389 - 392
  • [42] Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
    Kuchay, Mohammad Shafi
    Krishan, Sonal
    Mishra, Sunil Kumar
    Farooqui, Khalid Jamal
    Singh, Manish Kumar
    Wasir, Jasjeet Singh
    Bansal, Beena
    Kaur, Parjeet
    Jevalikar, Ganesh
    Gill, Harmendeep Kaur
    Choudhary, Narendra Singh
    Mithal, Ambrish
    DIABETES CARE, 2018, 41 (08) : 1801 - 1808
  • [43] Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
    Patel, Preya J.
    Smith, David
    Connor, Jason P.
    Horsfall, Leigh U.
    Hayward, Kelly L.
    Hossain, Fabrina
    Williams, Suzanne
    Johnson, Tracey
    Stuart, Katherine A.
    Brown, Nigel N.
    Saad, Nivene
    Clouston, Andrew D.
    Irvine, Katharine M.
    Russell, Anthony W.
    Valery, Patricia C.
    Powell, Elizabeth E.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 2017
  • [44] Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Song, Tiantian
    Jia, Yujiao
    Li, Zelin
    Wang, Fei
    Ren, Luping
    Chen, Shuchun
    DIABETES THERAPY, 2021, 12 (06) : 1735 - 1749
  • [45] Application of body composition zones in boys with nonalcoholic fatty liver disease
    Choi, Minhye
    Lee, Seonhwa
    Bae, Sun Hwan
    Chung, Sochung
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2019, 24 (04) : 243 - 247
  • [46] Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Tiantian Song
    Yujiao Jia
    Zelin Li
    Fei Wang
    Luping Ren
    Shuchun Chen
    Diabetes Therapy, 2021, 12 : 1735 - 1749
  • [47] Insulinaemic status and nonalcoholic fatty liver disease in Bangladeshi type 2 diabetic subjects
    Zeba, Z.
    Alam, A.
    Zinnat, R.
    Ali, L.
    DIABETOLOGIA, 2010, 53
  • [48] Diabetic status and grade of nonalcoholic fatty liver disease are associated with lower baroreceptor sensitivity in patients with nonalcoholic fatty liver disease
    Singh, Akanksha
    Kumar, Mavidi S.
    Jaryal, Ashok K.
    Ranjan, Piyush
    Deepak, Kishore K.
    Sharma, Sanjay
    Lakshmy, Ramakrishnan
    Pandey, Ravindra M.
    Vikram, Naval K.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (08) : 956 - 961
  • [49] NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AS POTENTIAL RISK FACTOR OF CARDIOVASCULAR DISEASE AND ONCOLOGICAL DISEASE IN DIABETIC TYPE 2 PATIENTS
    Caroli, D.
    Nogara, A.
    Rosa-rizzotto, E.
    De Lazzari, F.
    Bariga, Boscolo A.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E131 - E131
  • [50] NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AS POTENTIAL RISK FACTOR OF CARDIOVASCULAR DISEASE AND ONCOLOGICAL DISEASE IN DIABETIC TYPE 2 PATIENTS
    Caroli, D.
    Nogara, A.
    Rosa-Rizzotto, E.
    Bariga, A. Boscolo
    Zanoni, S.
    De Boni, S.
    Cavallarin, G.
    Marafin, C.
    Inglese, M.
    Della Loggia, M.
    Peraro, L.
    Lobello, S.
    De Lazzari, F.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S288 - S289
12345